Cardiometabolic Young Investigator Grant Program
This grant funds early-career researchers to study how severe hypertriglyceridemia affects cardiovascular and metabolic diseases, supporting innovative research and mentorship in the field.
Funder: Ionis Pharmaceuticals
Due Dates: June 15, 2026 (Full application deadline) | September 14, 2026 (Acceptance deadline)
Funding Amounts: $50,000 per year; renewable for a second year (up to $100,000 total)
Summary: Supports early-career researchers conducting innovative research on severe hypertriglyceridemia and its impact on cardiovascular and metabolic diseases.
Key Information: For residents, fellows, or junior faculty within 3 years of postdoc; U.S. citizens, permanent residents, or select visa holders only.
Description
The Cardiometabolic Young Investigator Grant Program, offered by Ionis Pharmaceuticals, is designed to foster the next generation of researchers in the field of severe hypertriglyceridemia. The grant supports early-career clinicians and scientists in academic or non-profit institutions to conduct innovative translational, clinical, or applied research aimed at understanding the effects of chylomicron and triglyceride elevations on cardiovascular and metabolic diseases. The program emphasizes mentorship and professional development, encouraging high-quality research that can lead to new discoveries and improved patient outcomes.
